Original article
Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections
Alejandro Ortiz-Covarrubiasa,
, Edward Fangb, Philippe G. Prokocimerb, Shawn D. Flanaganb, Xu Zhuc, Jose Francisco Cabré-Márquezd, Toshiaki Tanakae, Julie Passarellf, Jill Fiedler-Kellyf, Esteban C. Nanninig
Corresponding author
orca0059@prodigy.net.mx
Corresponding author at: Hospital Civil de Guadalajara, Calle Hospital #278 S.H., Guadalajara, 44100 Jalisco, Mexico.
Corresponding author at: Hospital Civil de Guadalajara, Calle Hospital #278 S.H., Guadalajara, 44100 Jalisco, Mexico.
a Hospital Civil de Guadalajara, Guadalajara, Jalisco, Mexico
b Merck and Co, Inc., Kenilworth, NJ, USA
c Bayer HealthCare, Beijing, China
d Bayer HealthCare, Mexico City, Mexico
e Bayer Yakuhin, Osaka, Japan
f Cognigen Corporation, a subsidiary of Simulations Plus, Inc., Buffalo, NY, USA
g Facultad Ciencias Médicas, Universidad Nacional de Rosario, Sanatorio Británico, Rosario, Argentina
Read
6404
Timeswas read the article
2556
Total PDF
3848
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 79 | 33 | 112 |
| 2025 5 | 143 | 44 | 187 |
| 2025 4 | 124 | 31 | 155 |
| 2025 3 | 104 | 28 | 132 |
| 2025 2 | 65 | 36 | 101 |
| 2025 1 | 43 | 25 | 68 |
| 2024 12 | 40 | 36 | 76 |
| 2024 11 | 42 | 18 | 60 |
| 2024 10 | 23 | 21 | 44 |
| 2024 9 | 43 | 26 | 69 |
| 2024 8 | 45 | 38 | 83 |
| 2024 7 | 53 | 27 | 80 |
| 2024 6 | 52 | 24 | 76 |
| 2024 5 | 28 | 31 | 59 |
| 2024 4 | 50 | 26 | 76 |
| 2024 3 | 36 | 29 | 65 |
| 2024 2 | 25 | 18 | 43 |
| 2024 1 | 32 | 29 | 61 |
| 2023 12 | 24 | 37 | 61 |
| 2023 11 | 30 | 28 | 58 |
| 2023 10 | 24 | 33 | 57 |
| 2023 9 | 40 | 58 | 98 |
| 2023 8 | 26 | 17 | 43 |
| 2023 7 | 27 | 21 | 48 |
| 2023 6 | 36 | 24 | 60 |
| 2023 5 | 37 | 19 | 56 |
| 2023 4 | 33 | 14 | 47 |
| 2023 3 | 83 | 19 | 102 |
| 2023 2 | 43 | 19 | 62 |
| 2023 1 | 21 | 14 | 35 |
| 2022 12 | 47 | 20 | 67 |
| 2022 11 | 60 | 26 | 86 |
| 2022 10 | 57 | 25 | 82 |
| 2022 9 | 36 | 30 | 66 |
| 2022 8 | 28 | 30 | 58 |
| 2022 7 | 29 | 40 | 69 |
| 2022 6 | 25 | 44 | 69 |
| 2022 5 | 22 | 25 | 47 |
| 2022 4 | 34 | 27 | 61 |
| 2022 3 | 43 | 36 | 79 |
| 2022 2 | 37 | 28 | 65 |
| 2022 1 | 23 | 20 | 43 |
| 2021 12 | 38 | 56 | 94 |
| 2021 11 | 23 | 30 | 53 |
| 2021 10 | 23 | 25 | 48 |
| 2021 9 | 16 | 24 | 40 |
| 2021 8 | 24 | 30 | 54 |
| 2021 7 | 19 | 25 | 44 |
| 2021 6 | 25 | 17 | 42 |
| 2021 5 | 33 | 48 | 81 |
| 2021 4 | 55 | 81 | 136 |
| 2021 3 | 30 | 33 | 63 |
| 2021 2 | 22 | 12 | 34 |
| 2021 1 | 32 | 29 | 61 |
| 2020 12 | 36 | 25 | 61 |
| 2020 11 | 33 | 12 | 45 |
| 2020 10 | 25 | 23 | 48 |
| 2020 9 | 31 | 22 | 53 |
| 2020 8 | 25 | 11 | 36 |
| 2020 7 | 26 | 8 | 34 |
| 2020 6 | 23 | 10 | 33 |
| 2020 5 | 27 | 10 | 37 |
| 2020 4 | 33 | 6 | 39 |
| 2020 3 | 34 | 28 | 62 |
| 2020 2 | 58 | 25 | 83 |
| 2020 1 | 26 | 23 | 49 |
| 2019 12 | 22 | 20 | 42 |
| 2019 11 | 29 | 19 | 48 |
| 2019 10 | 20 | 26 | 46 |
| 2019 9 | 23 | 28 | 51 |
| 2019 8 | 34 | 41 | 75 |
| 2019 7 | 26 | 28 | 54 |
| 2019 6 | 20 | 19 | 39 |
| 2019 5 | 32 | 31 | 63 |
| 2019 4 | 24 | 23 | 47 |
| 2019 3 | 17 | 22 | 39 |
| 2019 2 | 22 | 20 | 42 |
| 2019 1 | 14 | 11 | 25 |
| 2018 12 | 22 | 21 | 43 |
| 2018 11 | 89 | 14 | 103 |
| 2018 10 | 334 | 32 | 366 |
| 2018 9 | 16 | 16 | 32 |
| 2018 7 | 1 | 1 | 2 |
| 2018 5 | 6 | 4 | 10 |
| 2018 4 | 31 | 12 | 43 |
| 2018 3 | 44 | 8 | 52 |
| 2018 2 | 28 | 16 | 44 |
| 2018 1 | 9 | 7 | 16 |
| 2017 12 | 23 | 16 | 39 |
| 2017 11 | 24 | 7 | 31 |
| 2017 10 | 18 | 6 | 24 |
| 2017 9 | 22 | 11 | 33 |
| 2017 8 | 14 | 7 | 21 |
| 2017 7 | 14 | 11 | 25 |
| 2017 6 | 13 | 8 | 21 |
| 2017 5 | 20 | 17 | 37 |
| 2017 4 | 5 | 24 | 29 |
| 2017 3 | 18 | 40 | 58 |
| 2017 2 | 7 | 4 | 11 |
| 2017 1 | 8 | 14 | 22 |
| 2016 12 | 37 | 32 | 69 |
| 2016 11 | 27 | 26 | 53 |
| 2016 10 | 21 | 30 | 51 |
| 2016 9 | 27 | 29 | 56 |
| 2016 8 | 45 | 38 | 83 |
| 2016 7 | 31 | 30 | 61 |
| 2016 4 | 2 | 0 | 2 |
Show all
